Winters, A. C., Minhajuddin, M., Stevens, B. M., Major, A., Bosma, G., Abbott, D., Miltgen, N., Yuan, J., Treece, A. L., Siegele, B. J., Ewalt, M. D., Gutman, J. A., Jordan, C. T. and Pollyea, D. A. (2020) “Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2023.283790.